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What are spectraplakins and 
what is so special about them? 
Spectraplakins are exceptionally long, 
intracellular proteins that have the rare 
ability to bind to all three cytoskeletal 
elements: actin, microtubules, 
and intermediate filaments. They 
are amongst the longest proteins 
encoded by animal genomes, with 
some isoforms over 8,000 amino 
acids in length, and when folded are 
predicted to extend 0.4 µm across 
the cell — this can be 10% of the 
diameter of a cell. Spectraplakins 
are critically important for tissue 
integrity and function, operating 
with single cytoskeleton elements as 
well as coordinating these elements. 
Therefore, if you are studying a 
cytoskeletal process, especially 
one that requires coordination 
between different cytoskeletal 
polymers, it would be wise to 
investigate a possible contribution by 
spectraplakins.
Are there human diseases linked to 
spectraplakins? Yes: mutations in 
one of the two human spectraplakin 
genes, dystonin (DST, also known 
as bullous pemphigoid antigen 
1, BPAG1), have been found in 
patients with hereditary sensory and 
autonomic neuropathy type VI and 
autosomal recessive epidermolysis 
bullosa simplex 2. The second 
spectraplakin gene, microtubule–actin 
crosslinking factor 1 (MACF1; also 
known as ACF7), has yet to be 
linked to any human diseases, but 
mice lacking MACF1/ACF7 die at 
gastrulation.
How would I find the spectraplakin 
genes in a newly sequenced 
genome? Spectraplakins are great 
examples of protein evolution by the 
generation of new combinations of 
domains. Their name arose because 
they combine features of two families 
of cytoskeletal linker proteins 
— spectrins and plakins (Figure 1A). 
Spectraplakins inherited from spectrin 
family members an amino-terminal 
actin-binding domain composed of 
two calponin homology domains, 
numerous spectrin repeats, and a 
calcium-binding EF hand domain. What appears to have arisen in 
spectraplakins are two sequence 
motifs that were in turn inherited by 
plakins: the plectin repeats, which 
form the intermediate-filament-binding 
domain, and the plakin domain. 
Spectraplakins also inherited the 
microtubule-binding GAS2 domain 
that is only shared with GAS2 and 
its paralogs GAR2 and GAR22, and 
therefore is the key domain that 
distinguishes spectraplakins from 
spectrins and plakins. Gene-finding 
software seems to struggle with the 
large spectraplakin genes, so they 
are often erroneously split into two or 
more genes. Thus, the best strategy 
for identifying a spectraplakin is to 
search for genes containing the GAS2 
domain, and then examine upstream 
genes (since the GAS2 domain is 
located near the carboxyl terminus) 
for spectrin and plectin repeats.
From current genome sequences 
we infer that spectraplakins 
arose in the metazoa; we first see 
a spectraplakin in the sponge 
Amphimedon queenslandica. 
More primitive organisms have 
spectrin family members, and 
GAS2-containing proteins, but no 
combinations of the two. The plectin 
repeats are not identifiable until 
bilateria, when they appear in single 
spectraplakin genes. The expansion 
of plakins from the spectraplakin 
occurred within the chordates: the 
cephalochordate Amphioxus has 
a single plectin-repeat-containing 
protein, while the urochordate Ciona 
has many.
If spectraplakins are so important, 
why are only one or two encoded per 
genome? This may be because each 
spectraplakin locus can generate 
a great variety of different protein 
isoforms. By using alternative start 
sites, different stops, and internal 
splicing, multiple spectraplakin 
isoforms — each with a different 
combination of domains — arise 
from each gene (Figure 1A). As an 
example, the dystonin locus can 
generate proteins with plectin and 
spectrin repeats like BPAG1b, or 
proteins without plectin repeats 
like BPAG1a, or proteins without 
spectrin repeats like BPAG1n/e. 
Spectraplakins are encoded by large 
gene loci containing many exons that 
generate exceptionally large mRNAs, 
up to 27 kb long. It is technically very 
difficult to generate cDNAs that are long enough to demonstrate that a 
particular combination of possible 
splicing events at each end has 
occurred within the same mRNA. 
So while it is possible to combine 
the different splicing events of the 
spectraplakin genes into many 
possible isoforms, we have little 
knowledge of their relative abundance 
or their specific functions.
Do spectraplakins always crosslink 
different cytoskeletal structures? 
No, in many cases spectraplakins 
bind just one particular cytoskeletal 
structure. The actual crosslinking 
of different cytoskeletal structures 
seems to be tightly regulated and the 
different domains of these gigantic 
proteins appear to communicate 
with each other. Fragments of 
spectraplakin containing just the 
actin-binding domain or GAS2 domain 
localise to actin or microtubules, 
respectively (Figure 1B). However, 
of greater interest is that in different 
cell types, full-length spectraplakin, 
containing both of these domains, 
associates with just the actin or 
microtubule cytoskeleton, indicating 
that one binding activity dominates. 
This dichotomy has also been 
observed in functional tests in 
Drosophila, e.g. tendon cells require 
the microtubule-binding activity, 
but not the actin-binding activity of 
spectraplakins. In other cases it can 
be clearly shown that crosslinking 
between actin and microtubules is 
necessary and sufficient: a mini-
spectraplakin containing just these 
two binding domains is fully functional 
in axon growth.
This association of spectraplakins 
with actin or microtubule structures 
is tightly regulated; for example, 
the phosphorylation of the mouse 
spectraplakin MACF1 by glycogen 
synthase kinase 3b (GSK3b) 
uncouples MACF1 from microtubules. 
Drosophila spectraplakins appear 
to have an inactive conformation, 
in which the actin-binding domain 
binds intramolecularly to the region 
containing the EF hand and GAS2 
domains. This inactive form still 
associates with growing microtubule 
tips via EB1, but requires an activation 
event to open up and crosslink 
actin and microtubules. Despite the 
similarities of EF hands of fly and 
vertebrate spectraplakins, calcium 
is not able to activate the Drosophila 
spectraplakin.
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Figure 1. Spectraplakins — giant cytoskeleton organisers.
(A) Table of spectraplakins found in worms, flies and mouse/human, with corresponding protein models at the right (‘?’ denotes a predicted 
spectraplakin isoform), and see (B) for the key of the particular protein domains). The box showing ‘Related proteins’ shows models of the 
spectrin protein a-Actinin and the plakin protein Plectin. The box showing ‘Evolution of spectraplakins’ illustrates the appearance of spectra-
plakins and plakins during metazoan evolution. (B) Illustration of some of the experimentally demonstrated functions of the distinct domains 
of spectraplakins. (This illustration is not comprehensive and we would like to apologise to all researchers whose work is not included in this 
summary.)What processes require 
spectraplakins? In all model 
systems studied so far, 
spectraplakins are crucial in cells 
that require an extensive and 
dynamic cytoskeleton, e.g. epithelial, 
neural, and migrating cells. The 
loss of spectraplakin function leads 
to a variety of cellular defects 
due to disorganised cytoskeletal 
networks, which affect cell adhesion 
receptors, cell polarisation, organelle 
organisation, intracellular transport 
and nuclear positioning. As an 
example, loss of spectraplakins 
in worms, flies and mammals 
causes defects in cell migration by 
impairing the stability and directed 
polymerisation of microtubules. 
In worms, disrupted microtubule 
polymerisation affects nuclear 
positioning in the gonadal tip cells, 
altering their migration. In flies, 
defective dynamics and orientation of microtubules in axonal growth 
cones reduces their movement, 
causing shorter axons. In mouse 
fibroblasts, defective coupling of 
microtubules with actin stress fibers 
prevents microtubule regulation of 
focal adhesions and impairs cell 
migration.
What lies ahead? With improved 
knowledge of these cytoskeleton 
organisers we hope to understand 
how the coordination of the 
cytoskeleton drives morphogenesis, 
and devise strategies to alleviate 
diseases that arise from impaired 
spectraplakin function. To achieve 
this it will be important to elucidate 
how the many sequence alterations 
of spectraplakins, produced by 
alternative transcriptional start sites 
and splicing, impact on their function 
in different tissues, and to determine 
the molecular and structural mechanisms regulating spectraplakins 
in time and space.
Where can I find out more?
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